Print Magazine
Brussels Morning Newspaper
Thursday, August 18, 2022
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
No Result
View All Result
Home EU Institutions Commission

European Commission authorises fifth COVID-19 vaccine

Nikola Kiš by Nikola Kiš
21 December 2021
in Commission
US-biotech-company-Novavax.

Gaithersburg,,Ma,,Usa,,December,2021:,A,Syringe,Next,To,The

Share on FacebookShare on Twitter

Brussels (Brussels Morning) The European Commission has authorised its fifth COVID-19 vaccine – Nuvaxovid developed by the US biotech company Novavax. In a statement issued on Monday, the EC said that its authorisation is based on an assessment by the European Medicines Agency (EMA)’s and is supported by EU member states. 

EC President Ursula von der Leyen noted “at a time where the Omicron variant is rapidly spreading, and where we need to step up vaccination and the administration of boosters, I am particularly pleased with today’s authorisation of the Novavax vaccine.” She welcomed “the fifth safe and effective vaccine of our vaccine portfolio”, which, she noted, offers “additional protection to the European citizen against the pandemic.” She hoped that the latest authorisation would persuade those who have not been vaccinated against COVID-19 to take action and do so.

Stella Kyriakidou, the European Commissioner for Health and Food Safety, reiterated that the vaccine is “safe and effective”, pointing out that it is the first protein-based vaccine that the EC approved. She asserted that vaccination is necessary to stop the spread of coronavirus, emphasising that the newly approved shots are safe and effective. Kyriakidou said her message to EU citizens was simple: “vaccinate, vaccinate, vaccinate.”

According to the EC’s deal with Novavax, the company will deliver up to 100 million of the new shots to the EU in the first quarter of next year. The agreement allows for the possibility of increasing the figure to 200 million shots up to the end of 2023. To date and overall, the EU, with its 450 million or so citizens, has ordered more than 3.6 billion COVID-19 shots. 

Novavax first applied for approval of its vaccine in November. The EMA was able to approve it quickly because of having reviewed some of the data earlier as part of its rolling review process. After receiving the EC’s conditional marketing authorisation (CMA), manufacturers must provide additional data to confirm that the benefits of their products outweigh any risks that they might carry. CMA underpins the EU’s approach to mass vaccination push, having been  put in place for public health emergencies. Unlike regular market authorisation, CMA is based on incomplete data, which is why manufacturers are required to provide additional evidence following initial approval.

Tags: European Commission (LAH)Main-SliderNovavaxThe European Commission has authorised its fifth COVID-19 vaccine - Nuvaxovid developed by the US biotech company Novavax.

Latest post

Afghanistan: One year of agony

Afghanistan: One year of agony

2 days ago
EU burned areas reach new high due to wildfires

EU burned areas reach new high due to wildfires

2 days ago

Most Read

  • Losing Balance on Bosnia and Herzegovina

    Losing Balance on Bosnia and Herzegovina

    0 shares
    Share 0 Tweet 0
  • What Are The Highest Paying Jobs In Finland?

    0 shares
    Share 0 Tweet 0
  • Here Are 10 Highest Paying Jobs In Norway 

    0 shares
    Share 0 Tweet 0
  • What Are The Highest Paying Jobs In Luxembourg?

    0 shares
    Share 0 Tweet 0
  • These are the 10 highest paying jobs in the Europe in 2022

    0 shares
    Share 0 Tweet 0
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Belgium News
  • Brussels
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Print Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT